Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Institute of Molecular and Translational Medicine, Czech Republic
With
Palacky University
University Hospital Olomouc
Study has three study visits. First two visits are three months apart. Second and third visits are five months apart. On each study visit participant will provide venous blood sample and saliva sample obtained by gargling with the use of GARGTEST sampling kit. Participant will also fill in a questionnaire about SARS-CoV-2 infections and vaccinations. Site staff will measure the body temperature of the patient to exclude a patient with an acute infection. Blood sample will be used for the assessment of antibodies and cellular immunity of SARS-CoV-2. Part of the blood will be biobanked for the future SARS-CoV-2 biomarker determination. Gargling sample will be used for the demonstration of the pathogen on mucous membranes. Gargle self-sampling using GARGTEST sampling kit will be done by participants at 14-day intervals between the study visits. For gargle sample RT-PCR (real time polymerase chain reaction) will be done to determine the patogen presence.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participation in the SARS-CoV-2-CZ-PREVAL study and venous blood examined as part of this study
Signed study informed consent and consent to the processing of personal data
Adults (age 18 and over)
Willingness to complete the questionnaire
You may not be if
Participant with acute health problems
Clareo Health | Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region
